Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Marqeta Inc Cl A (NQ: MQ )

4.980 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Marqeta Inc Cl A

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Where Marqeta Stands With Analysts
Via Benzinga
Analyst Expectations for Marqeta's Future
Via Benzinga
Fintech Stocks like Affirm, SoFi Tech, Marqeta and Others Are Moving Today - Here's Why
Broker firm BTIG initiated coverage on fintech stocks. SoFi, Upstart, PayPal, Opurton Financial, and Jack Henry & Associates stocks are surging after the rating, while those of Affirm, Block, Marqeta,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
Via Benzinga
Analyst Ratings for Marqeta
Via Benzinga
Here's the Next Fintech Stock I'm Going to Buy
This company has an impressive customer list and a massive market opportunity. 
Via The Motley Fool
The Latest Analyst Ratings for Marqeta
Via Benzinga
Marqeta (MQ) Q1 2023 Earnings Call Transcript
MQ earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
Via Benzinga
The 3 Most Promising Fintech Stocks to Buy for June 2023
These fintech stocks to buy are trading near historical lows offering double-digit upside potential ahead at this time. 
Via InvestorPlace
What 11 Analyst Ratings Have To Say About Marqeta
Via Benzinga
Is Marqeta Stock a Buy Right Now?
Shares tanked after earnings, and the market remains focused on immediate-term risks. 
Via The Motley Fool
Marqeta Stock Is Trading Down Today: What's Going On?
Marqeta Inc (NASDAQ: MQ) shares are trading lower Wednesday after the company reported fourth-quarter results. 
Via Benzinga
3 Cheap Fintech Stocks to Buy Before the Comeback
Fintech stocks have been badly hurt. Here are three of the best cheap fintech stocks that can stage a comeback. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2023
Via Benzinga
3 Fintech Stocks to Buy Amid the Banking Blowout
These three fintech stocks each provide excellent upside potential for growth investors looking to make long-term bets right now. 
Via InvestorPlace
7 High-Risk, High-Reward Tech Stocks to Watch in 2023
While investors should take a cautionary approach at this juncture, certain high-risk, high-reward tech stocks appear compelling. 
Via InvestorPlace
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 27, 2023
Via Benzinga
Marqeta Analyst Turns Bullish, Sees 'Clear Path To Profitability'
Marqeta Inc (NASDAQ: MQ) stock has experienced a selloff, hitting 52-week lows on Thursday. 
Via Benzinga
5 Best Growth Stocks to Buy Now Under $10 (AI Stocks to Buy)
These 5 growth stocks leverage artificial intelligence and are beaten down from their highs. Are these stock picks diamonds in the rough that can supercharge your growth stock portfolio? 
Via The Motley Fool
10 Information Technology Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Marqeta Gets 33% Price Target Cut By Analysts, Cite Block Renewal Uncertainty
Keybanc analyst Josh Beck maintained Marqeta Inc (NASDAQ: MQ) with an Overweight and lowered 
Via Benzinga
Most Active Equity Options For Midday - Wednesday, March 1
Here are the most active equity options for midday. 
Via Talk Markets
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Dow Looking To Rebound After Rocky February
The Dow Jones Industrial Average is up 81 points this afternoon, while the S&P 500 Index and Nasdaq Composite are lower, with stocks kicking off a new month after a February decline. 
Via Talk Markets
12 Information Technology Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.